Skip to Main Content

Paper Details

Efficacy and safety of intravitreal anti-VEGF therapy in diabetic retinopathy: what we have learned and what should we learn further?
Expert Opin Biol Ther
17
2022
Author NameAffiliation
Quan Dong NguyenByers Eye Institute, Stanford University
  • 1 - 1

Datasets

Release 1.2